I-Antimicrobial Resistance (AMR) ngubhubhani othuleyo osongela impilo yehlabathi. Ngokutsho kwe-WHO, ukusweleka okunxulunyaniswa ne-AMR kunokufikelela kwi-10 yezigidi ngonyaka ngo-2050 ukuba kushiywe kungaqwalaselwa. Ngelixa ukusetyenziswa ngokugqithiseleyo kumayeza abantu kudla ngokugxininiswa,ikhonkco lokutya yindlela ebalulekileyo yosulelo- kunye nokujongwa ngokungqongqo kwentsalela ye-antibiotics yindlela yethu yokuqala yokuzikhusela.
Kutheni uKhuseleko lokuTya lubambe isitshixo ekulweni i-AMR
Amayeza okubulala iintsholongwane asetyenziswa kwimfuyo nasemanzini anokushiya iintsalela enyameni, ubisi, amaqanda, nobusi. Ukutya oku kutya kungcolisekileyo kuveza abathengi kwidosi ephantsi yokubulala iintsholongwane, kukhawulezisa uphuhliso lwebhaktheriya enganyangekiyo ngamachiza emathunjini omntu. Ezi pathogens zixhathisa zinokusasazeka kuluntu, zibeke esichengeni ukusebenza konyango olusindisa ubomi. Amaqumrhu alawulayo afana ne-FDA, i-EFSA, kunye neCodex Alimentarius aseke angqongqoUbuninzi beMida yeNtsalela (MRLs), kodwa unyanzeliso luxhomekeke ekubhaqweni okuchanekileyo, okunokwehla.
Umsantsa wokuBeka iliso: Imingeni kumaTyathanga oBonelelo boKutya kwiHlabathi liphela
Imimandla emininzi ayinafikelelo:
IziXhobo zokuHlola ezikwiNgxaki:Iimvavanyo ezikhawulezayo zihlala zingenabuntununtunu kwisizukulwana esitsha sokubulala iintsholongwane.
UQinisekiso oluPhezulu:IiLabs ziyasokola ngeendlela ezibizayo, ezicothayo ze-LC-MS/MS.
Iipaneli eziBanzi:Ukusetyenziswa kwe-antibiotics kufuna uhlalutyo lwentsalela eninzi.
Oku kudala iindawo ezingaboniyo apho iimveliso ezingahambelaniyo zingena kwiimarike, ziphembelela ingozi ye-AMR.
Kwinbon's Solutions: Ukuchongwa ngokuchanekileyo kwikamva lokutya okuKhuselekileyo
EBeijing Kwinbon, sinobunjineli beendlela zokubona ezibukhali ukuvala ezi zithuba:
Kwinbon RapidUvavanyoIikiti:Hambisa iziphumo ezikwisayithi ze>antibiotics ze-100 (i-β-lactam, i-sulfonamides, i-tetracyclines, njl.) kwimizuzu ye-15, ukuhlangabezana ne-EU/US MRLs. Ilungele iifama kunye nezityalo ezilungisayo.
Iiplatform ze-HPLC/LC-MS ezizenzekelayo:I-high-throughput, uhlalutyo oluqinisekisayo kunye ne-95% + ngokuchanekileyo, ukunciphisa iindleko zokusebenza kwelebhu nge-30% kunye neenkqubo eziqhelekileyo.
Iiphaneli zeNgqungquthela ezininzi eziLungisiweyo:Iipateni zokusetyenziswa kwezibulala-ntsholongwane ezijoliswe kummandla othile (umz., i-nitrofurans e-Asia, i-fluoroquinolones kumazwe aseMelika).
I-Case in Impact: Ukukhusela ukuthengiswa kweeDari kumazwe angaphandle
Umthengisi wobisi ophambili waseAsia uphunyeziweKwinbon's β-lactam & tetracycline iimvavanyo ezikhawulezayokumaziko angama-23 okuqokelela. Iziphumo:
Intsalela yeziganeko zokungathotyelwa ↓ 82% phakathi kweenyanga ezi-6
Ukwaliwa kokuthumela ngaphandle okunxulumene neZero kwi-AMR ngo-2024
Ugcino lweendleko zovavanyo lonyaka: ~$420,000
Indlela eya Phambili: Dibanisa ukubeka iliso, Yaphula iChain ye-AMR
Ulawulo olusebenzayo lwentsalela ayikokuthotyelwa nje kuphela – luyimfuneko yempilo yehlabathi. Njengoko i-FAO igxininisa, "Ukubeka iliso kulo lonke ikhonkco lexabiso lokutya akunakuxoxisana malunga nesiqulatho se-AMR."
Iqabane kunye Precision
IBeijing Kwinbon ixhobisa iifama, iiprosesa, kunye neelebhu nge:
✅Itekhnoloji yobungqina bexesha elizayo:Ukulungelelaniswa nee-MRL ezintsha kunye nezingcolisi ezivelayo
✅Ukuqukumbela ukuya esiphelweni:Ukusuka ekuhlolweni ukuya kwisiqinisekiso esiqinisekisiweyo
✅Ukuthotyelwa kweHlabathi:Izisombululo eziqinisekisiweyo ngokuchasene ne-ISO 17025, i-FDA BAM, i-EU 37/2010
Khusela abathengi, khusela urhwebo, kwaye ulwe ne-AMR ngokujongwa kwentsalela eqhutywa yisayensi.Qhagamshelana neKwinbon namhlanje ukuze wakhe inkqubo yokhuseleko lokutya eyomelelayo.
Ixesha lokuposa: Jun-18-2025